Dermatological Manifestations Associated with COVID-19: A Comprehensive Review of the Current Knowledge

July 2021 in “ Journal of Medical Virology ”

Zeinab Mohseni Afshar, Arefeh Babazadeh, Amir Hossein Hasanpour, Mohammad Barary, Babak Sayad, Alireza Janbakhsh, Zeinab Aryanian, Soheil Ebrahimpour

telogen effluvium anagen effluvium alopecia areata androgenetic alopecia topical corticosteroids antihistamines anticoagulants antimicrobial agents antifungal agents hair shedding hair loss hair thinning male pattern baldness steroid creams allergy medications blood thinners antibiotics antifungals

Studysummary This review focuses on the various skin symptoms associated with COVID-19 but reports no new clinical findings.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

12 / 12 results

research The Role of Androgens in COVID-19

40 citations , October 2020 in “Diabetes and Metabolic Syndrome: Clinical Research and Reviews”

This review discusses the potential role of androgens in increasing susceptibility to severe COVID-19 complications in men but presents no new clinical findings.

research Enanthem in Patients With COVID-19 and Skin Rash

91 citations , July 2020 in “JAMA Dermatology”

This study suggests that minoxidil may improve hypotrichosis in patients with ARWH due to LIPH variants, but a possible genetic factor could affect its efficacy within families.

research Caution in the Time of Rashes and COVID-19

7 citations , July 2020 in “Journal of The American Academy of Dermatology”

This article discusses the challenges of attributing skin manifestations to COVID-19, emphasizing the need for more studies to differentiate virus-specific lesions from nonspecific ones, and reports no new clinical results.

research Cutaneous Manifestations and Considerations in COVID-19 Pandemic: A Systematic Review

101 citations , July 2020 in “Dermatologic therapy”

This systematic review reports that "COVID toes" and other skin manifestations can be initial signs of COVID-19, and advises immunosuppressive therapy adjustments only for infected or at-risk patients.

Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature

research Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature

80 citations , June 2020 in “Dermatopathology”

This review discusses the various skin lesions associated with COVID-19, which vary in type and severity, and reports that these lesions can appear before other symptoms and typically resolve spontaneously.

research Patients With Specific Skin Disorders Affected by COVID-19: What Do Experiences Say About Management Strategies? A Systematic Review

31 citations , June 2020 in “Dermatologic Therapy”

This systematic review reports that for patients with underlying dermatologic disorders who contracted COVID-19, most experienced mild to moderate exacerbation of their skin conditions and were managed similarly to the general population, suggesting treatment discontinuation during acute infection may prevent severe recurrence.

research Acute Generalized Exanthematous Pustulosis Induced by Hydroxychloroquine Prescribed for COVID-19

26 citations , June 2020 in “The Journal of Allergy and Clinical Immunology In Practice”

This case study highlights that even short-term use of hydroxychloroquine for COVID-19 can potentially lead to acute generalized exanthematous pustulosis as an adverse effect.

research Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign'

119 citations , May 2020 in “Journal of The American Academy of Dermatology”

This study observed a high prevalence of androgenetic alopecia in patients hospitalized with severe COVID-19, with 79% of men and 42% of women affected, suggesting a potential link between androgen sensitivity and COVID-19 severity.

research Cutaneous Signs in COVID-19 Patients: A Review

176 citations , May 2020 in “Dermatologic Therapy”

This review discusses the cutaneous symptoms associated with COVID-19 and their potential use in diagnosing and assessing the severity of the disease, but it reports no new clinical results.

research COVID-19 with Dermatologic Manifestations and Implications: An Unfolding Conundrum

67 citations , May 2020 in “Dermatologic Therapy”

This review describes skin manifestations and reactions related to COVID-19 and COVID-19-related lifestyle changes but does not include new clinical data.

research Drug-Induced Hair Color Changes

36 citations , November 2016 in “European journal of dermatology/EJD. European journal of dermatology”

This review examines systemic drugs that can cause changes in hair color and emphasizes the importance of reporting these adverse events, but it does not include new clinical outcomes.

research Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin

15 citations , January 2014 in “Dermatology”

This study found a relatively low prevalence of cutaneous reactions in chronic hepatitis C patients treated with peginterferon alfa and ribavirin, with reactions correlated to age and treatment duration.